LOS
ANGELES, Aug. 19, 2024 /PRNewswire/
-- Agilisium, a premier digital innovations partner for Life
Sciences companies, today announced that it has been chosen as a
leader by the Everest Group in their Life Sciences Digital Services
for Mid-Market Enterprises PEAK Matrix® Assessment report, 2024.
The assessment study involved the evaluation of the vision,
capability (strategy, scope of services, innovation, delivery
footprint), and market impact (market adoption, portfolio mix, and
value delivered) of over 26 niche providers and their range of
offerings for Life Sciences enterprises globally.
Agilisium counts 7 of Top 10 Mid-market
Life Sciences companies as its clients through its 20+ Gen
AI-powered Solutions
Life Sciences mid-market enterprises are agile, have ambitious
growth plans, and look for innovation-led differentiation to create
value. Agilisium's values resonate with their expectations and is
one of their proud partners. To this end, the Everest Group
evaluated Agilisium's capabilities across the Life Sciences value
chain—from discovery through clinical trials, manufacturing, and
sales and marketing—along with client case studies and
references.
"Being recognized as a Leader by an independent research firm,
the Everest Group, is a significant testament to our commitment to
delivering superior digital solutions that address the pressing
needs of the life sciences industry. It is also a validation of
Agilisium's specialized expertise leveraging our digital services
for the Life Sciences industry," said Raj Babu, Founder and CEO of
Agilisium. He further added, "To specifically address the unique
needs of mid-market enterprises, backed by data across LS
functions, Agilisium has created a collaborative ecosystem that
brings together leading life sciences-centric partners, technology
majors, academia, and research institutions. It has also invested
significantly in Agilisium Labs, a dedicated innovation sandbox
that focuses on building advanced analytics and GenAI solutions
across the Life Sciences value chain."
"Mid-market life sciences enterprises face unique challenges
that distinguish them from their larger counterparts, necessitating
distinct sourcing needs, such as client intimacy, agility, and
cost-effective innovation, to stay competitive. Recognizing these
specific needs, providers are tailoring their strategies to offer
personalized support and innovative solutions, capitalizing on the
increasing mid-market demand. Agilisium's investments in building
domain-specific IP, and innovation labs, complemented by its
commitment to proactively deliver value in client engagements, has
helped it to earn a Leader position in Everest Group's Life
Sciences Digital Services for Mid-market Enterprises PEAK Matrix®
Assessment 2024," says Durga Ambati, Practice Director at Everest
Group.
To download the full report, click here.
Agilisium counts seven of the top 10 mid-market life sciences
companies as its clients. The company has brought on board seasoned
technology and domain experts, attracting senior talent from some
of the top Life Sciences companies such as Novartis, Amgen, Bayer,
UCB, and Sanofi to build next-generation solutions that address the
structural shifts in the industry.
About Agilisium
Agilisium is one of the premier Life
Sciences partners for digital innovations. The company delivers
cutting-edge solutions that drive impactful change by combining our
strong domain expertise with Data, Cloud, GenAI, and Advanced
Analytics. Agilisium collaborates with leading pharma and biotech
companies to provide data-driven insights and innovative solutions
across the value chain, helping accelerate drug discovery, optimize
patient care, achieve commercial success, streamline product
delivery, and foster collaboration. Learn more
at www.Agilisium.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/agilisium-recognized-as-a-leader-in-everest-group-life-sciences-digital-services-for-mid-market-enterprises-peak-matrixreport-302225512.html
SOURCE Agilisium Consulting